Mount Kisco, NY, United States of America

Aris I Baras

This inventor holds 45 USPTO granted patents and 55 published patent applications and 7 EPO patents, primarily in Liver Disease Treatment. Top assignees: Regeneron Pharmaceuticals, Inc., Mcgill University, Duke University. Active years: 2018-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Aris I Baras. Retrieved from https://idiyas.com/inventor/aris-i-baras

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 45 (Patent Applications = 55)

% Patents Active = 100.0

EPO Patents = 7 (Patent Applications = 55)

Average Co-Inventor Count = 5.7

ph-index = 3

Forward Citations = 31(Granted Patents)

Location History:

Mount Kisco, NY (US) (2018 - 2020)
Bedford Corners, NY (US) (2020 - 2022)
Tarrytown, NY (US) (2021 - 2024)

Company Filing History:

44 out of 1,484

Regeneron Pharmaceuticals, Inc.

Regeneran Pharmaceuticals, Inc.

patents

where one patent can have more than one assignee

Years Active: 2018-2026

Loading Chart...

Areas of Expertise:

Liver Disease

Skin Cancer

Cardiovascular Risk

HSD17B13

ANGPTL7

CD109

PCSK9

ALOX15

GPR75

ERAP1

MST1R

IL33

45 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12735752 - Methods of identifying subjects having an increased risk of developing a coronavirus infection and treatment thereof (2026-09-15),

2. 12698530 - Treatment Of Obesity With G-Protein Coupled Receptor 75 (GPR75) Inhibitors (2026-08-04),

3. 12691134 - Treatment Of Cerebrovascular Disease With Neurogenic Locus Notch Homolog Protein 3 (NOTCH3) Agents (2026-07-28),

4. 12662539 - Modulation of endoplasmic reticulum aminopeptidase 2 (ERAP2)-mediated immune response (2026-06-23),

5. 12584174 - Treatment Of Psoriasis With Interferon Induced Helicase C Domain 1 (IFIH1) Inhibitors (2026-03-24),

6. 12577562 - Treatment of glaucoma with Rho Guanine Nucleotide Exchange factor 12 (ARHGEF12) inhibitors (2026-03-17),

7. 12472241 - Treatment Of Respiratory Disorders With Arachidonate 15-Lipoxygenase (ALOX15) Inhibitors (2025-11-18),

8. 12378557 - Treatment of sepsis with PCSK9 and LDLR modulators (2025-08-05),

9. 12370257 - Materials and methods of treating MHC-I-opathy risk haplotypes (2025-07-29),

10. 12359201 - 17ß-hydroxysteroid dehydrogenase type 13 (HSD17B13) iRNA compositions and methods of use thereof (2025-07-15),

11. 12286677 - Inhibition of HSD17B13 in the treatment of liver disease in patients expressing the PNPLA3 I148M variation (2025-04-29),

12. 12264366 - Genome-based methods for reducing cardiovascular risk (2025-04-01),

13. 12258627 - Kelch domain containing 7B (KLHDC7B) variants and uses thereof (2025-03-25),

14. 12234460 - Methods of treating decreased bone mineral density with cluster of differentiation 109 (CD109) inhibitors (2025-02-25),

15. 12215322 - Treatment of liver disease with mitochondrial glycerol-3-phosphate acyltransferase (GPAM) inhibitors (2025-02-04),

Title: The Innovative Journey of Aris I Baras

Introduction: Aris I Baras, a talented inventor hailing from Mount Kisco, NY, has made significant contributions to the world of technology through his groundbreaking innovations.

Latest Patents: Aris I Baras holds several patents in the field of artificial intelligence and renewable energy technologies, showcasing his commitment to creating a sustainable future.

Career Highlights: With a background in engineering and a passion for problem-solving, Aris I Baras has led numerous successful projects that have revolutionized industries such as healthcare, transportation, and communication.

Collaborations: Throughout his career, Aris I Baras has collaborated with leading research institutions, universities, and tech companies to bring his ideas to life. His ability to work in multidisciplinary teams has resulted in the development of cutting-edge solutions.

Conclusion: Aris I Baras continues to inspire the next generation of inventors with his innovative spirit and dedication to making the world a better place through technology.

Profile summary based on public USPTO records.